Synthetic MUC1 breast cancer vaccine containing a Toll-like receptor 7 agonist exerts antitumor effects

Adjuvant immunotherapy has recently emerged as a potential treatment strategy for breast cancer. The tumor-associated protein mucin 1 (MUC1) has received increasing attention due to its high expression in numerous types of common tumors, in which MUC1 acts as a cancer antigen. However, the simple mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu, Tang, Li, Gao, Ningning, Diao, Yuwen, Zhong, Jingjing, Deng, Yongqiang, Wang, Zhulin, Jin, Guangyi, Wang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400475/
https://www.ncbi.nlm.nih.gov/pubmed/32782554
http://dx.doi.org/10.3892/ol.2020.11762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400475/
https://www.ncbi.nlm.nih.gov/pubmed/32782554
http://dx.doi.org/10.3892/ol.2020.11762

Ejemplares similares